129 related articles for article (PubMed ID: 6889921)
21. VP-16 in the treatment of malignant lymphomas: a report from the Swiss Group for Clinical Cancer Research (SAKK).
Cavalli F
Semin Oncol; 1985 Mar; 12(1 Suppl 2):33-6. PubMed ID: 3975656
[TBL] [Abstract][Full Text] [Related]
22. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
Goldhirsch A; Joss R; Cavalli F; Brunner KW
Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
[No Abstract] [Full Text] [Related]
23. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
[TBL] [Abstract][Full Text] [Related]
24. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
[No Abstract] [Full Text] [Related]
25. Chemotherapy of refractory germ cell cancer with Etoposide.
Lederman GS; Garnick MB; Canellos GP; Richie JP
J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
[TBL] [Abstract][Full Text] [Related]
27. cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma.
Veronesi A; Zagonel V; Santarossa M; Tirelli U; Galligioni E; Trovo' MG; Tumolo S; Grigoletto E
Cancer Chemother Pharmacol; 1983; 11(1):35-7. PubMed ID: 6683999
[TBL] [Abstract][Full Text] [Related]
28. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
[TBL] [Abstract][Full Text] [Related]
29. A review of etoposide in patients with non-small-cell lung cancer (NSCLC).
Itri LM; Gralla RJ
Cancer Treat Rev; 1982 Jun; 9 Suppl():115-8. PubMed ID: 6889916
[No Abstract] [Full Text] [Related]
30. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
Kimura K; Yamada K; Yoshida T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
[TBL] [Abstract][Full Text] [Related]
31. Ifosfamide and etoposide as salvage therapy for non-Hodgkin's lymphoma.
Hagberg H; Cavallin-Ståhl E; Lind J
Scand J Haematol; 1986 Jan; 36(1):61-4. PubMed ID: 3952466
[TBL] [Abstract][Full Text] [Related]
32. [Etoposide in the treatment of recurrent malignant lymphoma].
Háber J; Klener P
Vnitr Lek; 1986 Apr; 32(4):379-85. PubMed ID: 3727425
[No Abstract] [Full Text] [Related]
33. Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancer.
Chambers SK; Chambers JT; Kohorn EI; Schwartz PE
Gynecol Oncol; 1987 Jun; 27(2):233-40. PubMed ID: 3570062
[TBL] [Abstract][Full Text] [Related]
34. Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimen.
Judson IR; Wiltshaw E
Cancer Chemother Pharmacol; 1985; 14(3):258-61. PubMed ID: 4039635
[TBL] [Abstract][Full Text] [Related]
35. Etoposide (VP-16-213).
Issell BF; Crooke ST
Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
[No Abstract] [Full Text] [Related]
36. [Combination of etoposide with cisplatin or cyclophosphamide in the treatment of mouse Lewis lung carcinoma].
Uchida T; Okamoto K; Nishikawa K; Takahashi K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):75-9. PubMed ID: 3753643
[TBL] [Abstract][Full Text] [Related]
37. Review of etoposide.
Phillips NC; Lauper RD
Clin Pharm; 1983; 2(2):112-9. PubMed ID: 6309469
[No Abstract] [Full Text] [Related]
38. Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Lonial S; Arellano M; Hutcherson D; Langston A; Flowers C; Heffner LT; Winton E; Jo Lechowicz M; Waller EK
Leuk Lymphoma; 2006 Oct; 47(10):2155-62. PubMed ID: 17071490
[TBL] [Abstract][Full Text] [Related]
39. [Phase II study of etoposide in malignant lymphoma].
Onoshi T; Hayashi K; Ueoka H; Nishihara R; Toyota K
Gan To Kagaku Ryoho; 1984 Apr; 11(4):952-3. PubMed ID: 6721509
[No Abstract] [Full Text] [Related]
40. Etoposide--an effective single drug for treating bronchogenic carcinoma.
Anderson G; Peel ET; Cheong CM; Broderick NJ
Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
